Human Immunology Biosciences IPO

Human Immunology Biosciences, or HI-Bio, is a biotechnology company using human genetic and immunological research. With a mission to develop precise therapies for patients with immune-mediated diseases (IMDs), HI-Bio focuses on draining the cellular drivers of these diseases to grow their programs to other IMD indicators through clinical-stage programming and pipeline. Human Immunology Biosciences was founded by Travis Murdoch in 2021 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for Human Immunology Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Human Immunology Biosciences

Forge green plus iconForge green minus icon

What is Human Immunology Biosciences's IPO price?

The IPO price for Human Immunology Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Human Immunology Biosciences?

Human Immunology Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Human Immunology Biosciences shares pre-IPO?

If you own Human Immunology Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Human Immunology Biosciences a publicly traded company?

Human Immunology Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Human Immunology Biosciences founded?

Human Immunology Biosciences was founded in 2021.

Who are Human Immunology Biosciences's major investors?

Viking Global Investors
Arch Venture Partners
Alpha Wave Global
Arkin Holdings
Monograph Capital
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.